| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8213054 | International Journal of Radiation Oncology*Biology*Physics | 2017 | 32 Pages |
Abstract
Patients with p16-positive OPC exhibited better baseline QOL but showed a more dramatic QOL drop with concurrent chemoradiation. Given the favorable prognosis of p16-positive OPC, efforts to reduce the QOL burden of treatment are warranted.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Jolie MD, Richard PhD, Lester MD, Andy MD, Brian MD, June MD, Lizbeth MD, Walter MD, Chris MD, Danny MD,